TORONTO, Oct. 8 /CNW/ - Amorfix Life Sciences, a company focused on
treatments and diagnostics for brain wasting diseases, today announced that
Dr. Neil Cashman, Chief Scientific Officer of Amorfix, will present a poster
describing the sheep scrapie results from two blinded sheep scrapie panels
using Amorfix's prototype EP-TSE(TM) Blood Screening Assay at the Prion 2008
Conference today in Madrid, Spain. The presentation entitled, "Detection of
prions in blood from asymptomatic scrapie sheep using Epitope Protection
technology" highlights the sensitivity and specificity of the EP-TSE(TM) sheep
scrapie assay.
